Expression, purification and characterization of recombinant onconase expressed in Pichia pastoris.
- Author:
Ganggang YANG
;
Chengkai MA
;
Quanyi ZHANG
;
Shihui SHI
;
Ze WANG
;
Zhongyuan LÜ
;
Xuyang WANG
;
Xiaoya XU
;
Qingqing CUI
;
Jihong ZHANG
;
Ruigang ZHANG
;
Cunshuan XU
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
metabolism;
Bioreactors;
Cell Line, Tumor;
Codon;
DNA, Complementary;
Genetic Vectors;
Humans;
Pichia;
metabolism;
Recombinant Proteins;
biosynthesis;
Ribonucleases;
biosynthesis
- From:
Chinese Journal of Biotechnology
2015;31(11):1632-1642
- CountryChina
- Language:Chinese
-
Abstract:
Ranpirnase (onconase, ONC) is a new drug, with weak RNase activity and strong cytotoxicity to various tumor cells in vitro and in vivo. This study is to obtain recombination onconase (rONC) with high bioactivity. Based on the codon preference of Pichia pastoris, we designed and synthesized the gene according to cDNA sequences of ONC and the α mating factor's prepeptide. We screened positive clones after transforming the recombination plasmids into P. pastoris X-33, GSS115 and SMD1168. We screened the best combination of seven different vectors and host strains. Moreover, we optimized culture condition in shake flasks and 10 L bioreactor, and purified rONC from the supernatant after inducing it with 0.25% methanol by aqueous two-phase extraction coupling G50 molecular exclusion method. The highest rONC production was 13 mg/L in pPICZα-A/X-33/ONC combination under the condition of pH 5.5 and 23 degrees C in shake flasks for 7 d; and that the highest rONC production was 180 mg/L when the induction is performed in the lower basic salt medium with pH 5.5 in the 10 L bioreactor for 7 d. The yield of rONC is more than 90% at a purity of above 95%. rONC can kill various tumor cells in vitro. The expression and purification of rONC would be useful for further investigation of this new drug.
